| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
52,249 |
44,616 |
$10.33M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
51,601 |
44,051 |
$6.74M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,298 |
10,920 |
$3.06M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
31,166 |
25,646 |
$2.41M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,004 |
11,711 |
$1.53M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,830 |
10,957 |
$609K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,942 |
3,659 |
$351K |
| 71046 |
Radiologic examination, chest; 2 views |
6,876 |
6,315 |
$313K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,266 |
4,867 |
$258K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,310 |
5,730 |
$256K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,413 |
1,346 |
$167K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
793 |
345 |
$146K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,308 |
1,255 |
$131K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,923 |
5,387 |
$110K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
469 |
425 |
$85K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,403 |
2,164 |
$75K |
| 36415 |
Collection of venous blood by venipuncture |
85,581 |
74,767 |
$74K |
| 87800 |
|
2,238 |
2,115 |
$66K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,373 |
2,261 |
$61K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,356 |
2,247 |
$60K |
| 71045 |
Radiologic examination, chest; single view |
1,303 |
1,192 |
$60K |
| 80053 |
Comprehensive metabolic panel |
68,908 |
62,156 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,486 |
3,319 |
$55K |
| 86900 |
|
771 |
706 |
$55K |
| 86850 |
|
3,052 |
2,847 |
$41K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,582 |
808 |
$41K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
75,594 |
67,830 |
$40K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,789 |
3,510 |
$36K |
| 86780 |
|
3,193 |
3,002 |
$28K |
| 80061 |
Lipid panel |
3,142 |
2,898 |
$23K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
184 |
167 |
$22K |
| 97597 |
|
338 |
156 |
$22K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
571 |
492 |
$22K |
| 0240U |
|
212 |
202 |
$20K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
609 |
523 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,226 |
2,960 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
902 |
846 |
$17K |
| 70450 |
Computed tomography, head or brain; without contrast material |
223 |
190 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,667 |
2,437 |
$13K |
| 87081 |
|
3,483 |
3,289 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,305 |
9,344 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
349 |
343 |
$12K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
269 |
251 |
$8K |
| 84439 |
|
1,436 |
1,357 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
851 |
795 |
$7K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
55 |
27 |
$7K |
| 82652 |
|
288 |
274 |
$6K |
| 99201 |
|
54 |
37 |
$6K |
| 0450 |
Emergency room services |
144 |
120 |
$6K |
| 73630 |
|
141 |
130 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
132 |
40 |
$4K |
| 73221 |
|
24 |
24 |
$4K |
| 80074 |
|
93 |
92 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$3K |
| 87150 |
|
128 |
127 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,468 |
12,328 |
$2K |
| 82950 |
|
606 |
577 |
$2K |
| 85027 |
|
535 |
474 |
$2K |
| 84480 |
|
223 |
203 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17 |
13 |
$2K |
| 81003 |
|
6,320 |
5,822 |
$2K |
| 86803 |
|
442 |
396 |
$2K |
| 87631 |
|
133 |
129 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
269 |
204 |
$1K |
| 87340 |
|
518 |
477 |
$1K |
| 87077 |
|
500 |
405 |
$1K |
| 84702 |
|
110 |
88 |
$1K |
| 99070 |
|
76 |
52 |
$959.66 |
| 82043 |
|
296 |
271 |
$881.22 |
| 81001 |
|
19,403 |
17,839 |
$856.94 |
| J3490 |
Unclassified drugs |
71 |
58 |
$845.87 |
| 82570 |
|
312 |
287 |
$841.62 |
| 73610 |
|
13 |
12 |
$831.60 |
| 85610 |
|
3,798 |
2,738 |
$817.29 |
| 97162 |
|
16 |
12 |
$776.28 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,863 |
1,446 |
$753.64 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
522 |
459 |
$748.97 |
| 86705 |
|
92 |
85 |
$638.40 |
| 83690 |
|
9,102 |
8,425 |
$634.78 |
| 86762 |
|
401 |
362 |
$609.93 |
| 82607 |
|
54 |
53 |
$550.26 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$532.62 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
99 |
92 |
$482.81 |
| 87641 |
|
31 |
31 |
$364.91 |
| 87640 |
|
31 |
31 |
$364.91 |
| 83615 |
|
474 |
370 |
$342.87 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
13 |
12 |
$333.33 |
| 87070 |
|
127 |
105 |
$331.20 |
| 87186 |
|
122 |
113 |
$295.84 |
| 87581 |
|
12 |
12 |
$277.19 |
| 87486 |
|
12 |
12 |
$277.19 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
88 |
66 |
$256.50 |
| 84146 |
|
15 |
15 |
$231.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,321 |
1,249 |
$219.97 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,146 |
1,952 |
$170.76 |
| 87205 |
|
127 |
105 |
$164.16 |
| 85730 |
|
726 |
643 |
$137.10 |
| 84481 |
|
12 |
12 |
$135.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,029 |
2,773 |
$99.11 |
| 85007 |
|
56 |
41 |
$92.53 |
| 84484 |
|
4,134 |
3,575 |
$76.19 |
| 80069 |
|
15 |
13 |
$64.15 |
| 86901 |
|
759 |
694 |
$30.24 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
805 |
756 |
$25.62 |
| 83605 |
|
844 |
763 |
$24.06 |
| 80164 |
|
12 |
12 |
$23.24 |
| 81025 |
|
1,677 |
1,617 |
$21.35 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
51 |
29 |
$10.36 |
| 83735 |
|
878 |
765 |
$4.82 |
| 82962 |
|
91 |
69 |
$2.62 |
| 80179 |
|
12 |
12 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
196 |
92 |
$0.00 |
| A6446 |
Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard |
22 |
13 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
93 |
82 |
$0.00 |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
103 |
53 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
12 |
$0.00 |
| 87634 |
|
53 |
53 |
$0.00 |
| 82805 |
|
13 |
12 |
$0.00 |
| 84100 |
|
12 |
12 |
$0.00 |
| 80143 |
|
12 |
12 |
$0.00 |
| 87040 |
|
24 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
517 |
428 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
331 |
317 |
$0.00 |
| 83880 |
|
56 |
52 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
759 |
691 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
15 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
229 |
213 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
25 |
25 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
46 |
39 |
$0.00 |
| 86140 |
|
72 |
71 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
128 |
75 |
$0.00 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
82 |
37 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
91 |
76 |
$0.00 |
| 94761 |
|
142 |
132 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
133 |
117 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
52 |
50 |
$0.00 |
| 94760 |
|
15 |
13 |
$0.00 |
| 84703 |
|
57 |
55 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
13 |
12 |
$0.00 |
| 85379 |
|
15 |
15 |
$0.00 |
| A6252 |
Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
32 |
14 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
44 |
43 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
62 |
25 |
$0.00 |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
26 |
13 |
$0.00 |